Lack of H‐2 restriction of the Plasmodium falciparum (NANP) sequence as multiple antigen peptide
- 1 September 1991
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 21 (9) , 2273-2276
- https://doi.org/10.1002/eji.1830210941
Abstract
The major surface antigen of malaria sporozoites, the circumsporozoite protein, contains a region of tandem amino acid repeats, which in the case of the human malaria parasite Plasmodium falciparum, consist of four amino acids Asn‐Ala‐Asn‐Pro (NANP) repeated up to about 40 times. This repetitive sequence has been considered as the basis for the development of subunit vaccines against P. falciparum malaria. We and others had previously shown that synthetic and recombinant NANP peptides were immunogenic only in H‐2b mice. In the present report we show that, when mice with different H‐2 haplotypes are immunized with the repetitive NANP sequence incorporated in a synthetic branching multiple antigen peptide (MAP), all except one of the mouse strains tested mounted an anti‐peptide antibody response. Such a response does not appear to be due to the peculiar assembly of the NANP sequence. In fact, MAP containing repetitive sequences from circumsporozoite proteins of other malaria parasites did not overcome the genetic restriction of the immune response to the linear peptides. These data show that in the case of the P. falciparum NANP repeats, their immunogenicity can be dramatically changed and increased when these peptides are assembled as MAP. This unexpected finding may be of interest in the design of synthetic candidate malaria vaccines.Keywords
This publication has 19 references indexed in Scilit:
- A multiple antigen peptide from the repetitive sequence of the Plasmodium malariae circumsporozoite protein induces a specific antibody response in mice of various H‐2 haplotypesEuropean Journal of Immunology, 1990
- Plasmodium berghei Subunit Vaccine: Repeat Synthetic Peptide of Circumsporozoite Protein Comprising T- and B-Cell Epitopes Fails to Confer ImmunityScandinavian Journal of Immunology, 1990
- Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria.The Journal of Experimental Medicine, 1990
- Circumsporozoite Protein Heterogeneity in the Human Malaria Parasite Plasmodium vivaxScience, 1989
- 1H‐nmr studies of synthetic polypeptide models of Plasmodium falciparum circumsporozoite protein tandemly repeated sequenceBiopolymers, 1989
- Rationale for the Development of an Engineered Sporozoite Malaria VaccinePublished by Elsevier ,1989
- Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system.Proceedings of the National Academy of Sciences, 1988
- Genetic restriction of the murine humoral response to a recombinant Plasmodium vivax circumsporozoite proteinEuropean Journal of Immunology, 1988
- Variation among circumsporozoite protein genes from rodent malariasMolecular and Biochemical Parasitology, 1988
- Genetic control of the immune response in mice to a Plasmodium falciparum sporozoite vaccine. Widespread nonresponsiveness to single malaria T epitope in highly repetitive vaccine.The Journal of Experimental Medicine, 1986